ArticleFrontiers in neurology2025

SAFE-CGRP study: multicenter retrospective evaluation of the safety of CGRP pathway-targeting monoclonal antibodies in migraine with relevant comorbidities or conditions excluded from trials.

Cristina Sanabria-Gago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.